Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease

被引:7
|
作者
Posenau, J. Trevor
Wojdyla, Daniel M.
Shaw, Linda K.
Alexander, Karen P.
Ohman, E. Magnus
Patel, Manesh R.
Smith, Peter K.
Rao, Sunil V.
机构
[1] Washington Univ, Sch Med, Div Cardiovasc, St Louis, MO 63110 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Div Cardiovasc & Thorac Surg, Durham, NC USA
来源
ANNALS OF THORACIC SURGERY | 2017年 / 104卷 / 01期
关键词
BYPASS SURGERY; INTERVENTION; AGE; STENTS;
D O I
10.1016/j.athoracsur.2016.10.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Balancing risks and benefits of revascularization in elderly patients with multivessel coronary artery disease (CAD) is challenging. The appropriate revascularization strategy for elderly patients with multivessel CAD is unclear. Methods. We used the Duke Databank for Cardiovascular Disease to identify patients aged 75 years or more who had multivessel disease and treatment with percutaneous coronary intervention or coronary artery bypass graft surgery (CABG) within 30 days of the index catheterization between October 1, 2003, and June 30, 2013. The primary outcome was a composite of all-cause death, myocardial infarction, and coronary revascularization through latest follow-up. Associations between baremetal stents (BMS), drug-eluting stents (DES), CABG, and outcomes were determined using multivariable Cox proportional hazards modeling, adjusting for potential confounders with CABG as the reference. Comparisons between BMS and DES were done using BMS as the reference. Results. We identified 763 patients who met the criteria (BMS, n = 202; DES, n = 411; CABG, n = 150). The median age was 79 years (interquartile range, 76 to 82), and the median follow-up was 6.28 years. After adjustment, both BMS and DES were associated with a higher risk of the primary outcome. The BMS versus CAB Ghazard ratio was 1.58 (95% confidence interval: 1.15 to 2.19, p = 0.01). The DES versus CABG hazard ratio was 1.45 (95% confidence interval: 1.08 to 1.95, p = 0.01). The adjusted hazard ratio for DES versus BMS (0.92, 95% confidence interval: 0.71 to 1.19, p = 0.51) was not statistically significant. Conclusions. In this single-center analysis of 763 elderly patients with multivessel disease, CABG was associated with the best overall clinical outcomes, but was selected for a minority of patients. An adequately powered, randomized trial should be considered to define the best treatment strategy for this population. (C) 2017 by The Society of Thoracic Surgeons
引用
收藏
页码:107 / 115
页数:9
相关论文
共 50 条
  • [21] Real-world Comparing Outcomes of Revascularization Strategies for Multivessel Disease in Patients with Diabetes
    Zheng, Zhe
    Zhang, Heng
    Yuan, Xin
    Xu, Bo
    Rao, Chenfei
    Wang, Wei
    Hu, Shengshou
    CIRCULATION, 2014, 130
  • [22] Revascularization in Patients With Diabetes and Multivessel Coronary Artery Disease: A Population Based Evaluation of Outcomes
    Ramanathan, Krishnan
    Abel, Jim
    Park, Julie E.
    Fung, Anthony
    Gao, Min
    Ding, Lillian
    Taylor, Carolyn M.
    Humphries, Karin H.
    Farkouh, Michael E.
    CIRCULATION, 2015, 132 (23) : 2281 - 2281
  • [23] Real-world comparing outcomes of revascularization strategies for multivessel disease in patients with diabetes
    Zhang, Heng
    Yuan, Xin
    Xu, Bo
    Wang, Yang
    Hu, Shengshou
    Zheng, Zhe
    CARDIOLOGY, 2014, 129 : 87 - 87
  • [24] Complete Revascularization and Clinical Outcomes of Patients with Multivessel Disease
    Bartunek, Jozef
    Barbato, Emanuele
    Kornowski, Ran
    Unterseeh, Thierry
    Teiger, Emmanuel
    Joly, Patrick
    Ostojic, Miodrag
    Koning, Rene
    Goicolea, Javier
    Wessely, Rainer
    Danzi, Gian Battista
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B60 - B60
  • [25] The Role of Gender in Revascularization Strategies for Acute Coronary Syndrome and Multivessel Disease
    Horn, Patrick
    Haschemi, Jafer
    Kelm, Malte
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 217 : 153 - 155
  • [26] Revascularization strategies for multivessel coronary artery disease based on sex and age
    Sulaiman, Samian
    Harik, Lamia
    Merz, C. Noel Bairey
    Fremes, Stephen E.
    Creber, Ruth Masterson
    Rong, Lisa Q.
    Alkhouli, Mohamad
    Gaudino, Mario
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2023, 64 (05)
  • [27] Coronary artery revascularization in hemodialysis patients with multivessel coronary artery disease
    Hsu, Chan-Yang
    Chen, Yih-Sharng
    FORMOSAN JOURNAL OF SURGERY, 2016, 49 (02) : 45 - 48
  • [28] Clinical impact of complete revascularization in elderly patients with multivessel coronary artery disease underwent percutaneous coronary intervention
    Harada, M.
    Miura, T.
    Kobayashi, H.
    Kobayashi, T.
    Kobayashi, M.
    Kimura, H.
    Akanuma, H.
    Ebisawa, S.
    Miyashita, Y.
    Ikeda, U.
    EUROPEAN HEART JOURNAL, 2015, 36 : 167 - 167
  • [29] Revascularization strategies in STEMI and multivessel disease
    Almeida, Ines
    Chin, Joana
    Santos, Helder
    Santos, Mariana
    Miranda, Hugo
    Almeida, Samuel
    Sousa, Catarina
    Almeida, Lurdes
    ACTA CARDIOLOGICA, 2023, 78 (01) : 32 - 39
  • [30] Revascularization strategies in patients with multivessel coronary artery disease: a Bayesian network meta-analysis
    Van den Eynde, Jef
    Bomhals, Katrien
    Noe, Dries
    Jacquemyn, Xander
    McCutcheon, Keir
    Bennett, Johan
    Puskas, John D.
    Oosterlinck, Wouter
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (06) : 947 - 957